Many individuals on oral and injectable opioid treatment also use stimulants like cocaine and amphetamines, leading to increased illegal opioid use and treatment dropouts.
A study indicated that dextroamphetamine effectively reduces cravings for cocaine among these patients, prompting its prescription at a Vancouver clinic for stimulant use disorder.
Through focus groups and interviews, participants identified three key themes regarding dextroamphetamine's effectiveness: its ability to substitute for illicit stimulants, the importance of reaching the right dosage, and preferences for how the medication is accessed.